Clinical studies have demonstrated increased IL-6 levels in the cerebrospinal fluid of PMS patients (clinical biomarker studies), often correlating with progressive cortical thinning and gray matter atrophy [40,41,42,43,44]. This evidence concerns the gene IL6 and premenstrual tension.